122 related articles for article (PubMed ID: 33682555)
1. Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme.
Frempong SN; Shinkins B; Howdon D; Messenger M; Neal RD; Sagoo GS
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):417-427. PubMed ID: 33682555
[TBL] [Abstract][Full Text] [Related]
2. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
[TBL] [Abstract][Full Text] [Related]
4. Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.
Ravindrarajah R; Sutton M; Reeves D; Cotterill S; Mcmanus E; Meacock R; Whittaker W; Soiland-Reyes C; Heller S; Bower P; Kontopantelis E
PLoS Med; 2023 Feb; 20(2):e1004177. PubMed ID: 36848393
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model.
McManus E
Pharmacoecon Open; 2024 Apr; ():. PubMed ID: 38643282
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study.
McManus E; Meacock R; Parkinson B; Sutton M
Appl Health Econ Health Policy; 2023 Nov; 21(6):891-903. PubMed ID: 37787972
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care.
Gc VS; Suhrcke M; Hardeman W; Sutton S; Wilson ECF;
Value Health; 2018 Jan; 21(1):18-26. PubMed ID: 29304936
[TBL] [Abstract][Full Text] [Related]
10. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.
Farrar D; Simmonds M; Griffin S; Duarte A; Lawlor DA; Sculpher M; Fairley L; Golder S; Tuffnell D; Bland M; Dunne F; Whitelaw D; Wright J; Sheldon TA
Health Technol Assess; 2016 Nov; 20(86):1-348. PubMed ID: 27917777
[TBL] [Abstract][Full Text] [Related]
11. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
12. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders' perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers.
Rodrigues AM; Haste A; Penn L; Bell R; Summerbell C; White M; Adamson AJ; Sniehotta FF
BMC Health Serv Res; 2020 Apr; 20(1):307. PubMed ID: 32293424
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
Sharples L; Glover M; Clutterbuck-James A; Bennett M; Jordan J; Chadwick R; Pittman M; East C; Cameron M; Davies M; Oscroft N; Smith I; Morrell M; Fox-Rushby J; Quinnell T
Health Technol Assess; 2014 Oct; 18(67):1-296. PubMed ID: 25359435
[TBL] [Abstract][Full Text] [Related]
17. The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling.
Price A; Smith J; Dakin H; Kang S; Eibich P; Cook J; Gray A; Harris K; Middleton R; Gibbons E; Benedetto E; Smith S; Dawson J; Fitzpatrick R; Sayers A; Miller L; Marques E; Gooberman-Hill R; Blom A; Judge A; Arden N; Murray D; Glyn-Jones S; Barker K; Carr A; Beard D
Health Technol Assess; 2019 Jun; 23(32):1-216. PubMed ID: 31287051
[TBL] [Abstract][Full Text] [Related]
18. A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England.
Buyukkaramikli NC; Wigfield P; Hoang MT
Eur J Health Econ; 2021 Feb; 22(1):51-73. PubMed ID: 32901420
[TBL] [Abstract][Full Text] [Related]
19. Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT.
Perkins GD; Ji C; Achana F; Black JJ; Charlton K; Crawford J; de Paeztron A; Deakin C; Docherty M; Finn J; Fothergill RT; Gates S; Gunson I; Han K; Hennings S; Horton J; Khan K; Lamb S; Long J; Miller J; Moore F; Nolan J; O'Shea L; Petrou S; Pocock H; Quinn T; Rees N; Regan S; Rosser A; Scomparin C; Slowther A; Lall R
Health Technol Assess; 2021 Apr; 25(25):1-166. PubMed ID: 33861194
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]